Nucleic acids comprising formula (NuGlXmGmGnNv)a and derivatives thereof as an immunostimulating agents/adjuvants

Details for Australian Patent Application No. 2009210266 (hide)

Owner CureVac GmbH

Inventors Hoerr, Ingmar; Probst, Jochen; Kramps, Thomas; Voss, Sohnke

Agent Allens Arthur Robinson

Pub. Number AU-A-2009210266

PCT Pub. Number WO2009/095226

Priority 08001827.8 31.01.08 EP

Filing date 28 January 2009

Wipo publication date 6 August 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/095226 Priority application(s): WO2009/095226

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009210275-Methods to stabilize proteins and polypeptides

2009210221-The use of alternan as ingredient for certain foodstuffs